Oxipit and AstraZeneca join forces to aid early lung cancer detection
Oxipit and AstraZeneca have collaborated to do a joint pilot study, where Oxipit’s ChestEye Quality AI software is employed for improved pulmonary nodule detection.
Source
Oxipit and AstraZeneca have collaborated to do a joint pilot study, where Oxipit’s ChestEye Quality AI software is employed for improved pulmonary nodule detection.
Source